PHP Biotech

PHP Biotech Sponsors 3rd Annual Oncology Venture, Innovation & Partnering Summit in Cambridge

Southlake, Texas - October 08, 2026 - Nanobody developer joins investors and Big Pharma business development leaders as oncology dealmaking confronts a historic patent cliff. PHP Biotech International Inc., a...

🌐 Visit PHP Biotech →

PHP Biotech to Present Nanobody Panel and Sponsor 3rd Annual Oncology Venture, Innovation & Partnering Summit

Southlake, Texas - September 25, 2026 - PHP Biotech, a US-based biotechnology company specializing in nanobody and translational biotechnology, will participate in the 3rd Annual Oncology Venture, Innovation & Partnering...

🌐 Visit PHP Biotech →

PHP Biotech Identifies uPAR as the Cellular Entry Receptor for Its PHP53-nb Anti-Tumor Nanobody

Southlake, Texas - September 18, 2026 - Receptor finding supports tumor selectivity, opens a path to imaging-guided patient selection, and positions the p53-restoring nanobody within a target now being pursued...

🌐 Visit PHP Biotech →

PHP Biotech Announces Dual Role as Featured Speaker and Sponsor at Upcoming Oncology Summit

Southlake, Texas - September 11, 2026 - PHP Biotech, a US-based biotechnology company specializing in nanobody and translational biotechnology, will participate in the upcoming Oncology Summit as both a featured...

🌐 Visit PHP Biotech →

PHP Biotech Announces Participation as Sponsor and Presenter at 2026 Oncology Venture Summit

Southlake, Texas - August 03, 2026 - PHP Biotech, a US-based biotechnology company specializing in therapeutic nanobodies for cancer treatment, announced today its participation as both sponsor and featured presenter...

🌐 Visit PHP Biotech →